ความเสี่ยง (perpetual bond) 09/02/2560 แบบรายงาน/แบบฟอร์ม แบบลงนามรับทราบความเสี่ยง (SN) 09/02/2560 แบบรายงาน/แบบฟอร์ม แบบลงนามรับทราบความเสี่ยง (unrated+non investment grade bond) 09/02/2560 แบบ
แบบรายงาน/แบบฟอร์ม แบบลงนามรับทราบความเสี่ยง (perpetual bond) 09/02/2560 แบบรายงาน/แบบฟอร์ม แบบลงนามรับทราบความเสี่ยง (SN) 09/02/2560 แบบรายงาน/แบบฟอร์ม แบบลงนามรับทราบความเสี่ยง (unrated+non
7,698 mn, up by 5.2% YoY with a 6% YoY growth in net profit to THB 2,483 mn. Establishment of a Joint Venture to support business expansion plan On 5 September 2017, the Company established a new joint
unit in a government hospital to provide hemodialysis services (The nd branch) that still has focused on continuous expansion of dialysis unit. On the past 29th September, 2017 the subsidiary
focused on continuous expansion of dialysis unit. On the past 29 th September, 2017 the subsidiary additionally purchased assets from business of a dialysis unit which is business expansion as a plan laid
administrative expense to support business expansion. Without the non-recurring profit related to sale of Dusit Princess Korat, core EBITDA was THB 806 million, a 12.3% decrease from 2016. The Company reported net
slower rate in March and reached its bottom in April (-8.1% YoY), it made a v-shape recovery with 18.0% growth in June, partly driven by additional supply of C-Vitt from capacity expansion. - While Q2’20
network expansion led to increasing cost of service 3.9%YoY and 3.4%QoQ; however, SG&A was well-managed and dropped -12%YoY and -8.8%QoQ, resulted in stabilized EBITDA with -0.9%YoY and +1.6%QoQ. Net profit